Boston Scientific recently entered into a significant agreement with Bittium Biosignals Ltd. to supply ECG devices, valued between USD 30 to 45 million, which strengthens their cardiac diagnostics ...

In the latest market close, Boston Scientific (BSX) reached $104.50, with a -0.01% movement compared to the previous day. The stock's change was less than the S&P 500's daily gain of 0.4%.

Boston Scientific (BSX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Boston Scientific is throwing in the towel on its Acurate transcatheter aortic valve replacement, or TAVR, platform, citing rising costs of efforts to win regulatory approvals. Boston Scientific ...

Boston Scientific has pulled global sales of, and is no longer seeking FDA approval for, its Acurate neo2 and Acurate Prime aortic valve systems. In a May 28 Securities and Exchange Commission ...

Shares of Boston Scientific Corp. BSX slid 1.04% to $104.17 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 5,935. ...

Investing.com -- Shares of Boston Scientific (NYSE: BSX) tumbled 4% following the company’s announcement that it is halting global sales of its ACURATE neo2 and ACURATE Prime Aortic Valve Systems.

Boston Scientific Corporation (NYSE: BSX), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $157 billion, announced on Wednesday that it will ...

Bittium Biosignals Ltd. et Boston Scientific Cardiac Diagnostics Inc. ont signé un nouvel accord en vertu duquel Bittium fournira des appareils de mesure d'électrocardiogrammes pour la ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For the second quarter, the company estimates adjusted EPS, excluding certain charges, of $0.71 to $0.73, and net sales growth of between 17.5% and 19.5%. However, the company did not reaffirm its ...